DUX4L18: A Potential Drug Target and Biomarker (G100132421)

Target Name: DUX4L18

NCBI ID: G100132421

DUX4L18

Other Name(s): double homeobox 4 like 18 (pseudogene) | Double homeobox 4 like 18 (pseudogene) | DUXY2

DUX4L18: A Potential Drug Target and Biomarker

Dux4l18 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of COOH-rich C-type dipeptides (SPOPs), which are characterized by the presence of a specific COOH-rich region and a variable carboxylic acid residue. The function of Dux4l18 is not well understood, but it is thought to play a role in various physiological processes, including cell signaling, inflammation, and stress response.

Dux4l18 as a Drug Target

Dux4l18 has been identified as a potential drug target due to its unique structure and the processes it is involved in. One of the key reasons for its potential as a drug target is its unique expression pattern, which has been shown to be different between various tissues of the body. For example, Dux4l18 is highly expressed in the brain, heart, and kidneys, but is not expressed in other tissues, such as the liver or pancreas. This suggests that Dux4l18 may be a good target for drugs that are specific to these tissues.

In addition, Dux4l18 is involved in various signaling pathways that are relevant to many diseases, including cancer, neurodegenerative diseases, and inflammatory diseases. For example, Dux4l18 has been shown to be involved in the regulation of cell proliferation and differentiation, as well as in the regulation of inflammation and stress response. This suggests that Dux4l18 may be a good target for drugs that are designed to modulate these processes.

Dux4l18 as a Biomarker

Dux4l18 has also been identified as a potential biomarker for a variety of diseases. For example, Dux4l18 has been shown to be elevated in the blood of patients with various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. This suggests that Dux4l18 may be a useful biomarker for these conditions.

In addition, Dux4l18 has been shown to be elevated in the urine of patients with various diseases, including diabetes and hypertension. This suggests that Dux4l18 may be a useful biomarker for these conditions.

Conclusion

Dux4l18 is a protein that has been identified as a potential drug target and biomarker. Its unique expression pattern and involvement in various physiological processes make it an attractive target for drugs that are designed to modulate these processes. In addition, Dux4l18 has also been identified as a potential biomarker for a variety of diseases, including neurological and psychiatric disorders, diabetes and hypertension. Further research is needed to fully understand the function and potential of Dux4l18 as a drug target and biomarker.

Protein Name: Double Homeobox 4 Like 18 (pseudogene)

The "DUX4L18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUX4L18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets